• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results

    7/15/24 2:32:44 PM ET
    $AMIX
    $ASLN
    $DJT
    $GS
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMIX alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index rising more than 150 points on Monday.

    The Dow traded up 0.44% to 40,178.06 while the NASDAQ rose 0.29% to 18,451.73. The S&P 500 also rose, gaining, 0.25% to 5,629.59.

    Check This Out: Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying

    Leading and Lagging Sectors

    Energy shares jumped by 2% on Monday.

    In trading on Monday, utilities shares fell by 1.8%.

    Top Headline

    Goldman Sachs Group Inc. (NYSE:GS) reported better-than-expected results for its second quarter.

    Goldman posted revenue of $12.730 billion for the second quarter, beating the consensus of $12.456 billion. The U.S. financial services giant reported GAAP EPS of $8.62, beating the consensus of $8.35.

    Equities Trading UP
                           

    • Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) shares shot up 38% to $5.62 after the company announced in-vivo preclinical study results of NanoAb.
    • Shares of Autonomix Medical, Inc. (NASDAQ:AMIX) got a boost, surging 155% to $1.5250 after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) shares were also up, gaining 34% to $41.28 following the attempted assassination of Donald Trump.

    Equities Trading DOWN

    • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) shares dropped 46% to $1.35 after the company announced receipt of Nasdaq delisting determination.
    • Shares of Catheter Precision, Inc. (NYSE:VTAK) were down 14% to $3.29. Catheter Precision announced effectiveness of 1-for-10 reverse stock split.
    • Lexeo Therapeutics, Inc (NASDAQ:LXEO) was down, falling 27% to $12.77 after the company reported interim data of LX2006 for the treatment of Friedreich ataxia cardiomyopathy.

    Also Check This Out: This Analyst With 87% Accuracy Rate Sees More Than 12% Upside In AMD – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

    Commodities

    In commodity news, oil traded down 0.6% to $81.75 while gold traded up 0.5% at $2,433.00.

    Silver traded down 0.5% to $31.015 on Monday, while copper fell 1.6% to $4.5190.

    Euro zone

    European shares closed lower today. The eurozone's STOXX 600 fell 1.02, Germany's DAX fell 0.84% and France's CAC 40 fell 1.19%. Spain's IBEX 35 Index fell 0.96%, while London's FTSE 100 fell 0.85%.

    Industrial production in the Eurozone declined 0.6% month-over-month in May following a flat reading in the prior month.

    Asia Pacific Markets

    Asian markets closed mixed on Monday, with Hong Kong's Hang Seng Index falling 1.52%, China's Shanghai Composite Index gaining 0.09% and India's S&P BSE Sensex gaining 0.18%.

    Indian merchandise trade deficit increased to $21 billion in June from $20.1 billion in the year-ago period, while wholesale prices rose by 3.36% year-over-year in June following a 2.61% increase in the prior month. Total passenger vehicle sales in India surged 5.0% year-over-year to 294,133 in June.

    Chinese retail sales increased by 2% year-over-year in June, while industrial production climbed by 5.3% year-over-year in June. The Chinese economy expanded by 0.7% in the second quarter, compared to a revised 1.5% increase in the prior quarter.

    Economics

    The NY Empire State Manufacturing Index fell to a reading of -6.6 in July, compared to market estimates of -6.

    Now Read This: Top 5 Financials Stocks That May Collapse This Month

    Get the next $AMIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMIX
    $ASLN
    $DJT
    $GS

    CompanyDatePrice TargetRatingAnalyst
    Lexeo Therapeutics Inc.
    $LXEO
    12/18/2025$25.00Strong Buy
    Raymond James
    Lexeo Therapeutics Inc.
    $LXEO
    11/20/2025$19.00Overweight
    Cantor Fitzgerald
    Goldman Sachs Group Inc.
    $GS
    10/21/2025$750.00Overweight → Neutral
    Analyst
    Lexeo Therapeutics Inc.
    $LXEO
    10/15/2025$30.00Buy
    Guggenheim
    Goldman Sachs Group Inc.
    $GS
    10/3/2025$785.00Market Perform
    BMO Capital Markets
    Lexeo Therapeutics Inc.
    $LXEO
    7/31/2025$20.00Outperform
    Oppenheimer
    Goldman Sachs Group Inc.
    $GS
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Goldman Sachs Group Inc.
    $GS
    7/8/2025$627.00Hold → Reduce
    HSBC Securities
    More analyst ratings

    $AMIX
    $ASLN
    $DJT
    $GS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Otero Jose Manuel sold $19,294 worth of shares (3,016 units at $6.40), decreasing direct ownership by 2% to 125,460 units (SEC Form 4)

    4 - Lexeo Therapeutics, Inc. (0001907108) (Issuer)

    2/20/26 5:05:09 PM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Townsend Richard Nolan sold $64,924 worth of shares (10,173 units at $6.38), decreasing direct ownership by 3% to 392,483 units (SEC Form 4)

    4 - Lexeo Therapeutics, Inc. (0001907108) (Issuer)

    2/20/26 5:05:07 PM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: Chief Operating Officer Otero Jose Manuel sold $6,684 worth of shares (721 units at $9.27), decreasing direct ownership by 1% to 63,476 units (SEC Form 4)

    4/A - Lexeo Therapeutics, Inc. (0001907108) (Issuer)

    2/20/26 5:05:04 PM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMIX
    $ASLN
    $DJT
    $GS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel and Secretary Glabe Scott bought $10,465 worth of shares (1,000 units at $10.46), increasing direct ownership by 0.31% to 326,236 units (SEC Form 4)

    4 - Trump Media & Technology Group Corp. (0001849635) (Issuer)

    11/19/25 8:48:25 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Director Hess John B bought $1,997,584 worth of shares (3,904 units at $511.68) (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    4/17/25 4:06:04 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Director Johnson Kevin R bought $1,485,648 worth of shares (2,400 units at $619.02) (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    1/21/25 4:55:51 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AMIX
    $ASLN
    $DJT
    $GS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yorkville America Equities, LLC and Truth Social Funds Announce Proposed Acquisition of the Point Bridge America First ETF (MAGA)

    SARASOTA, Fla., Feb. 19, 2026 /PRNewswire/ -- Yorkville America Equities, LLC ("Yorkville"), investment adviser for the Truth Social Funds, today announced that it has entered into an agreement to acquire the Point Bridge America First ETF (Ticker: MAGA) into the Truth Social Funds product suite. The respective Board of Trustees of the Truth Social Funds and ETF Series Solutions have approved this transaction, which, if approved by shareholders, is expected to close in Q2 2026. The Truth Social Funds and each of its existing ETF series are part of the Truth.Fi fintech brand from Trump Media & Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media"), operator of the social media platf

    2/19/26 9:00:00 AM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

    THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Clarke Wilkirson, PhD, Clinical Development Engineer II, will present new long-term clinical data at the Society of Surgical Oncology (SSO) 2026 Annual Meeting, happening March 5-7, 2026, in Phoenix, Arizona. The presentation, titled "Pain Mitigation in Pancreatic Adenocarcinoma: A Long-Term Analysis of Denervation via Transvascular RF Energy-Based Ablation" (Submission ID: 2249416), has been accepted as an oral podium presentation. Dr. Wilkirson will deliver a fi

    2/19/26 8:30:00 AM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth

    FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (NYSE:VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive agreement to divest its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer. Following a comprehensive portfolio review, the Company determined that monetizing these non-core assets enhances capital efficiency and sharpens focus on its high-growth electrophysiology platform. Strategic Rationale Focus our capital allocation on core cardiac arrhythmia technologiesStrengthened balance sheetSimplified operating structure with enhanced strategic clarit

    2/19/26 8:15:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $AMIX
    $ASLN
    $DJT
    $GS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Lexeo Therapeutics with a new price target

    Raymond James initiated coverage of Lexeo Therapeutics with a rating of Strong Buy and set a new price target of $25.00

    12/18/25 9:11:03 AM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cantor Fitzgerald initiated coverage on Lexeo Therapeutics with a new price target

    Cantor Fitzgerald initiated coverage of Lexeo Therapeutics with a rating of Overweight and set a new price target of $19.00

    11/20/25 8:07:20 AM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Goldman Sachs downgraded by Analyst with a new price target

    Analyst downgraded Goldman Sachs from Overweight to Neutral and set a new price target of $750.00

    10/21/25 7:15:32 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AMIX
    $ASLN
    $DJT
    $GS
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/20/26 5:24:43 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/20/26 4:13:19 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/19/26 1:43:44 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AMIX
    $ASLN
    $DJT
    $GS
    Leadership Updates

    Live Leadership Updates

    View All

    Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced a series of key senior leadership appointments that underscore the company's continued and growing expertise in cardiovascular medicine and late-stage clinical development. The company also provided an update on the strategic partnership announced in June 2025 with Perceptive Xontogeny Venture Funds and venBio Partners to develop therapies for genetic cardiac diseases utilizing a novel non-viral RNA platform. Narinder Bhalla, MD has been appointed Chief Medical Officer, effective

    1/27/26 7:30:00 AM ET
    $LXEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Lambda Appoints Stacey Finerman as VP, Investor Relations

    Seasoned IR Leader from Zayo Group, Marqeta, and Square Brings Deep Expertise Lambda, the Superintelligence Cloud, today announced the appointment of Stacey Finerman as VP, Investor Relations. Finerman brings over a decade of experience in financial communications and capital markets strategy to support Lambda's next stage of growth as a leader in AI infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021703561/en/Stacey Finerman, VP, Investor Relations "We're delighted to have Stacey join our team. Stacey's significant experience strengthens our investor relations capabilities and adds a new set of relationships

    10/21/25 8:00:00 AM ET
    $C
    $EB
    $GS
    Major Banks
    Finance
    Computer Software: Programming Data Processing
    Technology

    Divcon Controls Names Marc Shiffman CEO

    With two decades of experience managing companies to exceptional results, Shiffman is well qualified to lead Divcon through a rapid phase of growth Divcon Controls ("Divcon"), a global systems integrator delivering facility management automation and monitoring solutions to the world's biggest mission-critical data center operators, announced today that Marc Shiffman has become its new Chief Executive Officer and has joined the company's Board of Directors. Mr. Shiffman joins Divcon with extensive experience in technology and services leadership, having successfully run multiple companies as an operationally adept executive in partnership with innovative founders. Most recently, Mr. Shif

    10/14/25 7:04:00 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AMIX
    $ASLN
    $DJT
    $GS
    Financials

    Live finance-specific insights

    View All

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Presidio Announces Proposed $1 Billion Acquisition Financing Facility with Goldman Sachs

    Acquisition Facility expected to accelerate asset acquisition strategy Fort Worth, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) --   Presidio Investment Holdings LLC ("Presidio" or the "Company"), a differentiated oil and gas operator focused on the acquisition and optimization of mature, producing oil and natural gas assets in the United States, and EQV Ventures Acquisition Corp. (NYSE:FTW) ("FTW"), a special purpose acquisition company sponsored by EQV Group, today announced that Presidio has mandated an affiliate of Goldman Sachs (NYSE:GS) to arrange up to $1.0 billion  in potential acquisition financing for Presidio following the completion of its business combination. Goldman Sachs Bank USA

    2/10/26 8:00:00 AM ET
    $EQV
    $FTW
    $GS
    Oil & Gas Production
    Energy
    Investment Bankers/Brokers/Service
    Finance

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $AMIX
    $ASLN
    $DJT
    $GS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    12/3/24 6:17:58 PM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    11/27/24 10:15:18 AM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Trump Media & Technology Group Corp.

    SC 13G/A - Trump Media & Technology Group Corp. (0001849635) (Subject)

    11/14/24 9:53:48 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology